story of the week
Birtamimab Plus Standard of Care in Patients With Newly Diagnosed Treatment-Naïve Light Chain Amyloidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial
Blood 2023 Jun 27;[EPub Ahead of Print], MA Gertz, AD Cohen, RL Comenzo, E Kastritis, HJ Landau, EN Libby, M Liedtke, V Sanchorawala, S Schönland, AD Wechalekar, JA Zonder, G Palladini, J Walling, S Guthrie, C Nie, C Karp, Y Jin, GG Kinney, G MerliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.